drugset / Trial / NCT01183442

Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia

NCT01183442

Phase 3 Terminated 22 enrolled Medical University of Graz
RandomizedParallel-groupDouble-blindTreatment

Summary

The main aim of the investigation is to clarify, whether vitamin D supplementation in coronary artery disease patients with vitamin D deficiency and postchallenge hyperglycemia has an impact on endothelial dysfunction and parameters of insulin sensitivity and beta-cell function.

Timeline

Start
2010-06
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin D Other / unclassified 2800 iu Oral